CLL-IPI applied in Binet A CLL: a nationwide cohort study

Blood Adv. 2022 Nov 8;6(21):5698-5701. doi: 10.1182/bloodadvances.2021006259.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Prognosis